Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure of a human Tcf4-beta-catenin complex.

F Poy1, M Lepourcelet, R A Shivdasani

  • 1Department of Cancer Biology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115, USA.

Nature Structural Biology
|November 20, 2001
PubMed
Summary

Disrupting the Tcf4-beta-catenin interaction, crucial in colon cancer, is a therapeutic target. Researchers determined the crystal structure of this human complex, revealing key insights for drug development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Expression of Concern: Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia.

Leukemia·2026
Same author

Dynamic Reprogramming of Stromal Pdgfra-expressing cells during WNT-Mediated Transformation of the Intestinal Epithelium.

bioRxiv : the preprint server for biology·2025
Same author

Progastrin production transitions from Bmi1<sup>+</sup>/Prox1<sup>+</sup> to Lgr5<sup>high</sup> cells during early intestinal tumorigenesis.

Translational oncology·2020
Same author

Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia.

Leukemia·2015
Same author

An integrative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer.

Oncogene·2013
Same author

Regulation of platelet biogenesis: insights from the May-Hegglin anomaly and other MYH9-related disorders.

Journal of thrombosis and haemostasis : JTH·2009

Area of Science:

  • Molecular Biology
  • Structural Biology
  • Cancer Research

Background:

  • Beta-catenin is a multifunctional protein vital for cell adhesion and Wnt signaling.
  • Mutations in Adenomatous polyposis coli (APC) or beta-catenin drive over 90% of colon cancers.
  • Elevated Tcf4-beta-catenin complexes in colonic epithelia promote polyp formation and malignancy.

Purpose of the Study:

  • To investigate the Tcf4-beta-catenin interaction as a potential therapeutic target for colon cancer.
  • To determine the crystal structure of the human Tcf4-beta-catenin complex.
  • To compare the human Tcf4-beta-catenin structure with related complexes.

Main Methods:

  • X-ray crystallography was used to determine the 3D structure of the human Tcf4-beta-catenin complex.

Related Experiment Videos

  • Comparative structural analysis was performed against Xenopus Tcf3 (XTcf3) and mammalian E-cadherin complexes.

    • Main Results:

    • The crystal structure of the human Tcf4-beta-catenin complex was successfully determined.
    • The structure showed expected similarities to the XTcf3 complex.
    • An unexpected difference was observed: the absence of a component present in the XTcf3 structure.

    Conclusions:

    • Understanding the Tcf4-beta-catenin complex structure provides a basis for developing targeted therapies.
    • The structural insights may guide the design of inhibitors to disrupt this cancer-promoting interaction.
    • Further research is needed to elucidate the functional significance of the structural differences observed.